DK0607401T3 - Partikler til NMR-billeddannelse og fremgangsmåde til fremstilling deraf - Google Patents

Partikler til NMR-billeddannelse og fremgangsmåde til fremstilling deraf

Info

Publication number
DK0607401T3
DK0607401T3 DK93917714.3T DK93917714T DK0607401T3 DK 0607401 T3 DK0607401 T3 DK 0607401T3 DK 93917714 T DK93917714 T DK 93917714T DK 0607401 T3 DK0607401 T3 DK 0607401T3
Authority
DK
Denmark
Prior art keywords
particles
core
glycerophospholipid
micellar
shell
Prior art date
Application number
DK93917714.3T
Other languages
Danish (da)
English (en)
Inventor
Roland Hyacinthe
Herve Tournier
Michel Schneider
Original Assignee
Bracco Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Int Bv filed Critical Bracco Int Bv
Application granted granted Critical
Publication of DK0607401T3 publication Critical patent/DK0607401T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1833—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with a small organic molecule
    • A61K49/1839—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with a small organic molecule the small organic molecule being a lipid, a fatty acid having 8 or more carbon atoms in the main chain, or a phospholipid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/832—Nanostructure having specified property, e.g. lattice-constant, thermal expansion coefficient
    • Y10S977/838—Magnetic property of nanomaterial
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/905—Specially adapted for travel through blood circulatory system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927—Diagnostic contrast agent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/932—Specified use of nanostructure for electronic or optoelectronic application
    • Y10S977/953—Detector using nanostructure
    • Y10S977/96—Of magnetic property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y10T428/2998—Coated including synthetic resin or polymer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Soft Magnetic Materials (AREA)
  • Oxygen, Ozone, And Oxides In General (AREA)
  • Hard Magnetic Materials (AREA)
DK93917714.3T 1992-08-13 1993-07-30 Partikler til NMR-billeddannelse og fremgangsmåde til fremstilling deraf DK0607401T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP92810618 1992-08-13
EP93810380 1993-05-25
PCT/EP1993/002046 WO1994004197A1 (fr) 1992-08-13 1993-07-30 Particules pour imagerie rmn et procede de fabrication

Publications (1)

Publication Number Publication Date
DK0607401T3 true DK0607401T3 (da) 1996-11-25

Family

ID=26132520

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93917714.3T DK0607401T3 (da) 1992-08-13 1993-07-30 Partikler til NMR-billeddannelse og fremgangsmåde til fremstilling deraf

Country Status (20)

Country Link
US (3) US5464696A (fr)
EP (1) EP0607401B1 (fr)
JP (1) JP2968588B2 (fr)
KR (1) KR100307773B1 (fr)
CN (1) CN1076205C (fr)
AT (1) ATE144714T1 (fr)
AU (1) AU660108B2 (fr)
CA (1) CA2119654C (fr)
DE (1) DE69305730T2 (fr)
DK (1) DK0607401T3 (fr)
ES (1) ES2094558T3 (fr)
FI (1) FI941677A (fr)
GR (1) GR3022288T3 (fr)
HU (1) HU221805B1 (fr)
IL (1) IL106493A (fr)
IS (1) IS1648B (fr)
MX (1) MX9304924A (fr)
NO (1) NO307244B1 (fr)
NZ (1) NZ254791A (fr)
WO (1) WO1994004197A1 (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465188B1 (en) 1990-06-11 2002-10-15 Gilead Sciences, Inc. Nucleic acid ligand complexes
DE4428851C2 (de) * 1994-08-04 2000-05-04 Diagnostikforschung Inst Eisen enthaltende Nanopartikel, ihre Herstellung und Anwendung in der Diagnostik und Therapie
US5520904A (en) * 1995-01-27 1996-05-28 Mallinckrodt Medical, Inc. Calcium/oxyanion-containing particles with a polymerical alkoxy coating for use in medical diagnostic imaging
TW319763B (fr) * 1995-02-01 1997-11-11 Epix Medical Inc
DE19508772C2 (de) * 1995-03-01 1998-01-29 Schering Ag Verfahren und Verbindungen zur Detektion von Analyten mittels Remanenzmessung und deren Verwendung
US8071737B2 (en) * 1995-05-04 2011-12-06 Glead Sciences, Inc. Nucleic acid ligand complexes
US5833948A (en) * 1995-06-15 1998-11-10 Bracco Research S.A. Blood-pool imaging composition comprising micelles containing a lipophilic chelating agent and a non-ionic surfactant
DE19529921C2 (de) * 1995-08-01 1997-09-25 Schering Ag Verwendung von MRT-Kontrastmitteln zur Ventilations-Bildgebung der Lunge
EP0800545B2 (fr) * 1995-11-01 2011-03-02 Bracco Research S.A. Systemes de marqueur moleculaire cible, a etiquetage magnetique, pour imagerie a resonance magnetique nucleaire
GB9600427D0 (en) * 1996-01-10 1996-03-13 Nycomed Imaging As Contrast media
WO1997025073A2 (fr) 1996-01-10 1997-07-17 Nycomed Imaging A/S Milieu de contraste
WO1998044910A1 (fr) 1997-04-09 1998-10-15 Philipp Lang NOUVELLE TECHNIQUE DE CONTROLE DE L'ADMINISTRATION DE MEDICAMENTS NON VULNERANTE $i(IN VIVO)
US6337215B1 (en) * 1997-12-01 2002-01-08 International Business Machines Corporation Magnetic particles having two antiparallel ferromagnetic layers and attached affinity recognition molecules
US6278893B1 (en) * 1998-01-05 2001-08-21 Nycomed Imaging As Method of magnetic resonance imaging of a sample with ex vivo polarization of an MR imaging agent
EP1118009A1 (fr) * 1998-09-28 2001-07-25 Nycomed Imaging As Procede d'imagerie par resonance magnetique
US6283448B1 (en) * 2000-04-19 2001-09-04 Daniel Webster Denton Offset butterfly valve
EP2279757A3 (fr) 2000-06-02 2011-08-03 Bracco Suisse SA Composés pour le ciblage de cellules endothéliales
DE60137953D1 (de) * 2000-10-06 2009-04-23 Life Technologies Corp Zellen mit spektraler signatur sowie verfahren zu ihrer herstellung und nutzung
US20050059031A1 (en) * 2000-10-06 2005-03-17 Quantum Dot Corporation Method for enhancing transport of semiconductor nanocrystals across biological membranes
US20090060992A1 (en) * 2002-05-08 2009-03-05 University Of Central Florida Research Foundation, Inc., Preparation of magneto-vesicles with DOPE/DDAB layers
KR101076053B1 (ko) 2003-02-04 2011-10-21 브라코 인터내셔날 비.브이. 초음파 조영제 및 그것의 제조방법
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
DE10331439B3 (de) * 2003-07-10 2005-02-03 Micromod Partikeltechnologie Gmbh Magnetische Nanopartikel mit verbesserten Magneteigenschaften
EP1696965B1 (fr) * 2003-12-22 2014-12-10 Bracco Suisse SA Systeme de microvesicule remplie de gaz a constituant actif pour l'imagerie de contraste
AU2004308756B2 (en) * 2003-12-22 2010-06-24 Bracco Suisse S.A. Gas-filled microvesicle assembly for contrast imaging
US20050260137A1 (en) * 2004-05-18 2005-11-24 General Electric Company Contrast agents for magnetic resonance imaging
US7229690B2 (en) 2004-07-26 2007-06-12 Massachusetts Institute Of Technology Microspheres including nanoparticles
JP4837663B2 (ja) 2004-08-18 2011-12-14 ブラッコ・シュイス・ソシエテ・アノニム 造影画像化のためのガス充填微小胞組成物
EP1787661A1 (fr) * 2004-09-10 2007-05-23 Toray Industries, Inc. Préparation thérapeutique
US20070264199A1 (en) * 2005-09-26 2007-11-15 Labhasetwar Vinod D Magnetic nanoparticle composition and methods for using the same
WO2007106683A2 (fr) * 2006-03-10 2007-09-20 The Trustees Of The University Of Pennsylvania Lipoproteine biomimetique contenant de l'oxyde de fer et substances apparentees
EP2061517B1 (fr) 2006-09-05 2010-06-02 Bracco Research S.A. Microvesicules remplies de gaz contenant des lipides modifies par polymeres
AU2007336297B2 (en) * 2006-12-18 2013-09-05 Colorobbia Italia S.P.A. Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application
US8784659B2 (en) * 2007-08-08 2014-07-22 General Electric Company Method for controlling microbial biofilm in aqueous systems
WO2009145813A1 (fr) * 2008-03-04 2009-12-03 Qd Vision, Inc. Particules comprenant des nanoparticules, leurs utilisations, et procédés
FR2934954B1 (fr) 2008-08-14 2011-07-22 Commissariat Energie Atomique Emulsion fluorescente de vert d'indocyanine
FR2934955B1 (fr) 2008-08-14 2011-07-08 Commissariat Energie Atomique Encapsulation d'agents therapeutiques lipophiles ou amphiphiles dans des nanoemulsions
FR2934953B1 (fr) 2008-08-14 2011-01-21 Commissariat Energie Atomique Nanoemulsions de nanocristaux
CA2748995C (fr) * 2008-10-07 2018-01-16 Bracco Suisse Sa Construction de ciblage comprenant un anticorps anti-polymere et des liposomes ou des microvesicules se liant a ceux-ci
WO2011031876A1 (fr) 2009-09-09 2011-03-17 Qd Vision, Inc. Formulations comprenant des nanoparticules
WO2011031871A1 (fr) 2009-09-09 2011-03-17 Qd Vision, Inc. Particules comprenant des nanoparticules, leurs utilisations, et procédés
JP5678565B2 (ja) * 2009-12-08 2015-03-04 Jnc株式会社 磁性微粒子およびその製造方法
US20110217379A1 (en) * 2010-03-08 2011-09-08 Davis Llp Magnetic nanomaterials and methods for chemoembolisation
KR101174470B1 (ko) 2010-04-08 2012-08-16 한국세라믹기술원 자성 실리카 리포좀 나노입자 및 이의 제조방법
TWI428284B (zh) * 2010-11-05 2014-03-01 Nat Univ Chung Cheng Sea urchin iron oxide and its manufacturing method
US8889103B2 (en) 2010-12-15 2014-11-18 General Electric Company Diagnostic agent composition and associated methods thereof
US8895068B2 (en) 2010-12-15 2014-11-25 General Electric Company Nanoparticle composition and associated methods thereof
WO2012136813A2 (fr) 2011-04-07 2012-10-11 Universitetet I Oslo Agents pour un diagnostic par radar médical
WO2014096165A2 (fr) 2012-12-21 2014-06-26 Bracco Suisse Sa Microvésicules remplies de gaz
WO2016191549A1 (fr) * 2015-05-26 2016-12-01 Intezyne Technologies Micelles stabilisées par du fer à utiliser en tant qu'agents de contraste magnétique
FR3103376B1 (fr) * 2019-11-26 2021-11-12 Univ Bordeaux Ferrofluide huileux biocompatible et procédé de préparation

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331654A (en) * 1980-06-13 1982-05-25 Eli Lilly And Company Magnetically-localizable, biodegradable lipid microspheres
US4331645A (en) * 1981-04-20 1982-05-25 Reynolds Metals Company Alumina from alkali metal-aluminum chloride complexes
NL194579C (nl) * 1983-01-21 2002-08-05 Schering Ag Diagnostisch middel.
JPS6072830A (ja) * 1983-09-29 1985-04-24 Kao Corp ベシクル用組成物
GB8408127D0 (en) * 1984-03-29 1984-05-10 Nyegaard & Co As Contrast agents
US4728575A (en) * 1984-04-27 1988-03-01 Vestar, Inc. Contrast agents for NMR imaging
DE3515373A1 (de) * 1985-04-27 1986-11-06 Merck Patent Gmbh, 6100 Darmstadt Stickstoffhaltige heterocyclen
US4675173A (en) * 1985-05-08 1987-06-23 Molecular Biosystems, Inc. Method of magnetic resonance imaging of the liver and spleen
JPS6295134A (ja) * 1985-10-21 1987-05-01 Nippon Saafuakutanto Kogyo Kk リポソ−ムの製造法
DE3619746A1 (de) * 1986-06-12 1987-12-17 Basf Ag Superparamagnetische feststoffteilchen
US4951675A (en) * 1986-07-03 1990-08-28 Advanced Magnetics, Incorporated Biodegradable superparamagnetic metal oxides as contrast agents for MR imaging
US5262176A (en) * 1986-07-03 1993-11-16 Advanced Magnetics, Inc. Synthesis of polysaccharide covered superparamagnetic oxide colloids
DK175531B1 (da) * 1986-12-15 2004-11-22 Nexstar Pharmaceuticals Inc Leveringsvehikel med amphiphil-associeret aktiv bestanddel
US4994429A (en) * 1986-12-29 1991-02-19 Aluminum Company Of America Active material useful as adsorbent comprising metal oxide/hydroxide particles reacted with phosphorus-containing organic acid group of organic compound having unreacted acid group
US5124289A (en) * 1986-12-29 1992-06-23 Aluminum Company Of America Surface treated permeable inorganic membranes and process of making same
US4929589A (en) * 1986-12-29 1990-05-29 Aluminum Company Of America Metal oxide/hydroxide particles coated with phosphate esters
US4983566A (en) * 1987-03-09 1991-01-08 Aluminum Company Of America Surface-modified adsorbent comprising metal oxide/hydroxide particles reacted with one or more perfluorinated organic acids
US5000960A (en) * 1987-03-13 1991-03-19 Micro-Pak, Inc. Protein coupling to lipid vesicles
DE3709851A1 (de) * 1987-03-24 1988-10-06 Silica Gel Gmbh Adsorptions Te Nmr-diagnostische fluessigkeitszusammensetzungen
JPH0720857B2 (ja) * 1988-08-11 1995-03-08 テルモ株式会社 リポソームおよびその製法
US5230882A (en) * 1989-12-22 1993-07-27 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
US5246707A (en) * 1990-04-26 1993-09-21 Haynes Duncan H Sustained release delivery of water-soluble bio-molecules and drugs using phospholipid-coated microcrystals, microdroplets and high-concentration liposomes
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
CA2046997C (fr) * 1990-07-16 2000-12-12 Hiroshi Kikuchi Liposomes
DE4100470A1 (de) * 1991-01-09 1992-07-16 Byk Gulden Lomberg Chem Fab Echokontrastmittel
JP3272736B2 (ja) * 1991-01-31 2002-04-08 協和醗酵工業株式会社 リポソーム製剤
CA2064683A1 (fr) * 1992-03-26 1993-09-27 Krishna Mohan Rao Kallury Formation d'enzymes thermostables possedant une extraordinaire tolerance a la chaleur par immobilisation sur des matrices de phospholipides
US5411730A (en) * 1993-07-20 1995-05-02 Research Corporation Technologies, Inc. Magnetic microparticles
US5494744A (en) * 1994-10-12 1996-02-27 Kimberly-Clark Corporation Method of applying a protein coating to a substrate and article thereof
US20120231528A1 (en) * 2009-11-10 2012-09-13 Microphyt Reaction casing for a photosynthetic reactor and associated photosynthetic reactor

Also Published As

Publication number Publication date
US5545395A (en) 1996-08-13
NO941311L (no) 1994-04-12
AU4705493A (en) 1994-03-15
EP0607401B1 (fr) 1996-10-30
GR3022288T3 (en) 1997-04-30
KR100307773B1 (ko) 2001-12-28
CN1076205C (zh) 2001-12-19
DE69305730T2 (de) 1997-05-28
DE69305730D1 (de) 1996-12-05
JPH07503976A (ja) 1995-04-27
ATE144714T1 (de) 1996-11-15
FI941677A0 (fi) 1994-04-12
HU221805B1 (hu) 2003-01-28
HUT75149A (en) 1997-04-28
WO1994004197A1 (fr) 1994-03-03
ES2094558T3 (es) 1997-01-16
NZ254791A (en) 1996-11-26
HU9401038D0 (en) 1994-07-28
IL106493A (en) 1997-02-18
AU660108B2 (en) 1995-06-08
US5587199A (en) 1996-12-24
EP0607401A1 (fr) 1994-07-27
IL106493A0 (en) 1993-11-15
JP2968588B2 (ja) 1999-10-25
IS1648B (is) 1997-03-25
US5464696A (en) 1995-11-07
NO941311D0 (no) 1994-04-12
NO307244B1 (no) 2000-03-06
CA2119654A1 (fr) 1994-03-03
CA2119654C (fr) 2001-02-06
CN1089470A (zh) 1994-07-20
IS4058A (is) 1994-02-14
FI941677A (fi) 1994-04-12
MX9304924A (es) 1994-08-31

Similar Documents

Publication Publication Date Title
DK0607401T3 (da) Partikler til NMR-billeddannelse og fremgangsmåde til fremstilling deraf
EP1208887A3 (fr) Méthode de contrôle d'objet
EP1136107A3 (fr) Système de jeu, support d'enregistrment lisible par ordinateur pour programme de jeu et méthode d'affichage d'image
DE69410466T2 (de) Verfahren und zusammensetzungen zur erhöhung des bild-kontrastes
EP1300182A3 (fr) Système et procédé pour fournir l'expérience de l'utilisateur pour jeu en réseau
JP2001316217A (ja) 水性透明組成物
ES2021942A6 (es) Procedimiento para preparar composiciones farmaceuticas a base de ciclosporinas.
IE811215L (en) Rapamycin composition
DE69813310D1 (de) Verfahren zur Herstellung von Alkylenoxidaddukten aus Fettsäureestern einwertiger Alkohole und Alkylenoxiden
DE60133482D1 (de) Mischung aus organophosphor-flammschutzmittel, lacton-stabilisator, und phosphat-kompatibilisierungmittel
IL126412A0 (en) Method of t-weighted magnetic resonance imaging of res organs
EP1151771A3 (fr) Système de jeu, procede d'imagerie dans la système de jeu, et support d'enregistrement lisible par ordinateur avec programme
JP7150403B2 (ja) クレンジング料
FR2449461A1 (fr) Perfectionnement a un jeu
SE9500759D0 (sv) Metod att avskärma den magnetiska delen i ett elektromagnetiskt fält
JPS63307709A (ja) 多極磁石集合体
Gair Three-dimensional spatial field and force distributions in axial field machines using a computed tomography method (three dimensional spatial field distributions)
KR920001490Y1 (ko) 자석이 내장된 넥타이
JPS57123252A (en) Antistatic polyester composition
Honkura et al. Development of Dental Magnetic Attachment with Rare Earth Magnet
Kind The highest order common sense